Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer
Open Access
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (6) , 932-940
- https://doi.org/10.1038/bjc.1998.154
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- UROKINASE-PLASMINOGEN ACTIVATOR, A NEW AND INDEPENDENT PROGNOSTIC MARKER IN BREAST-CANCER1990
- The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assaysEuropean Journal of Cancer and Clinical Oncology, 1990
- Plasminogen activator inhibitors: hormonally regulated serpinsMolecular and Cellular Endocrinology, 1990
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988
- Steroid receptors in breast cancer: Sources of inter-laboratory variation in dextran-charcoal assaysBreast Cancer Research and Treatment, 1987
- Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsThe Journal of cell biology, 1987
- Immunohistochemical Localization of Urokinase- and Tissue-Type Plasminogen Activators in Psoriatic SkinJournal of Investigative Dermatology, 1987
- Enzyme-Linked Immunosorbent Assay for Human Urokinase-Type Plasminogen Activator and its Proenzyme Using a Combination of Monoclonal and Polyclonal AntibodiesJournal of Immunoassay, 1986
- Monoclonal Antibodies to Human 54,000 Molecular Weight Plasminogen Activator Inhibitor from Fibrosarcoma Cells - Inhibitor Neutralization and One-Step Affinity PurificationThrombosis and Haemostasis, 1986
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985